Impact of COVID-19 on people with cystic fibrosis

Lancet Respir Med. 2020 May;8(5):e35-e36. doi: 10.1016/S2213-2600(20)30177-6. Epub 2020 Apr 15.

¹ Cystic Fibrosis Regional Reference Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Department of Pathophysiology and Transplantation, 20122 Milan, Italy. Electronic address: carla.colombo@unimi.it.
² Respiratory Medicine and National Cystic Fibrosis Reference Center, Cochin Hospital, Assistance Publique-Hôpitaux de Paris, Université de Paris, Institut Cochin, INSERM U1016, Paris, France.
³ Pediatric Pulmonology and Cystic Fibrosis Unit, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
⁴ Cystic Fibrosis Centre, Children's Hospital, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
⁵ Department of Pediatrics, Justus-Liebig-University, Giessen, Germany.
⁶ INSERM U1151, Institut Necker Enfants Malades, National Cystic Fibrosis Reference Center (paediatric site), Hôpital Necker Enfants Malades, Assistance Publique Hôpitaux de Paris Paris, ERN-Lung, Université de Paris, France.
⁷ Department of Women's and Children's Health, University of Liverpool, Institute in the Park, Alder Hey Children's Hospital, Liverpool, UK.

No abstract available

Publication types